Data di Pubblicazione:
2005
Citazione:
Pyridazine derivatives as novel acyl-CoA: cholesterol acyltransferase (ACAT) inhibitors / A. Gelain. - In: JOURNAL OF HETEROCYCLIC CHEMISTRY. - ISSN 0022-152X. - 42:3(2005), pp. 395-400.
Abstract:
Acyl-CoA:cholesterol acyltransferase (E.C.2.3.1.26, ACAT) is a microsomial enzyme that catalyses the formation of cholesteryl esters by acylation of cholesterol with long chain fatty acylCoA.
ACAT plays important roles in cellular homeostasis and in the early stages of atherosclerosis.
Therefore, ACAT inhibitors have been identified as useful agents in the treatment of hypercholesterolemia, atherosclerosis and coronary diseases. In addition, recently their application has been proposed for Alzheimer's disease.
Tipologia IRIS:
01 - Articolo su periodico
Elenco autori:
A. Gelain
Link alla scheda completa: